カテゴリー： QYResearch, 世界

鼻ポリープ治療の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Nasal Polyps Treatment Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18739）・商品コード：DATA909X18739
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：97
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、鼻ポリープ治療の世界市場について調査・分析し、鼻ポリープ治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬理療法、手術）、用途別（病院、外来手術センター、専門クリニック）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の鼻ポリープ治療市場動向
・主要企業別マーケットシェア
・鼻ポリープ治療の種類別市場規模2014-2019
（薬理療法、手術）
・鼻ポリープ治療の用途別市場規模2014-2019
（病院、外来手術センター、専門クリニック）
・鼻ポリープ治療の北米市場：主要企業・種類別/用途別市場規模
・鼻ポリープ治療のヨーロッパ市場：主要企業・種類別/用途別市場規模
・鼻ポリープ治療の中国市場：主要企業・種類別/用途別市場規模
・鼻ポリープ治療の日本国内市場：主要企業・種類別/用途別市場規模
・鼻ポリープ治療の東南アジア市場：主要企業・種類別/用途別市場規模
・鼻ポリープ治療のインド市場：主要企業・種類別/用途別市場規模
・鼻ポリープ治療の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（OptiNose US、Regeneron Pharmaceuticals、Merck、Pfizer、F. Hoffmann La-Roche、Intersect ENT、GlaxoSmithKline、Sanofi、Novartis）
・鼻ポリープ治療の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

In 2018, the global Nasal Polyps Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Nasal Polyps Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nasal Polyps Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
OptiNose US
Regeneron Pharmaceuticals
Merck
Pfizer
F. Hoffmann La-Roche
Intersect ENT
GlaxoSmithKline
Sanofi
Novartis

Market segment by Type, the product can be split into
Pharmacological Therapies
Surgeries

Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Specialty Clinics

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Nasal Polyps Treatment status, future forecast, growth opportunity, key market and key players.
To present the Nasal Polyps Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Nasal Polyps Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Nasal Polyps Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Pharmacological Therapies
1.4.3 Surgeries
1.5 Market by Application
1.5.1 Global Nasal Polyps Treatment Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Specialty Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Nasal Polyps Treatment Market Size
2.2 Nasal Polyps Treatment Growth Trends by Regions
2.2.1 Nasal Polyps Treatment Market Size by Regions (2019-2025)
2.2.2 Nasal Polyps Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Nasal Polyps Treatment Market Size by by Players
3.1.1 Global Nasal Polyps Treatment Revenue by by Players (2014-2019)
3.1.2 Global Nasal Polyps Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Nasal Polyps Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Nasal Polyps Treatment Key Players Head office and Area Served
3.3 Key Players Nasal Polyps Treatment Product/Solution/Service
3.4 Date of Enter into Nasal Polyps Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Nasal Polyps Treatment Market Size by Type (2014-2019)
4.2 Global Nasal Polyps Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Nasal Polyps Treatment Market Size (2014-2019)
5.2 Nasal Polyps Treatment Key Players in North America
5.3 North America Nasal Polyps Treatment Market Size by Type
5.4 North America Nasal Polyps Treatment Market Size by Application

6 Europe
6.1 Europe Nasal Polyps Treatment Market Size (2014-2019)
6.2 Nasal Polyps Treatment Key Players in Europe
6.3 Europe Nasal Polyps Treatment Market Size by Type
6.4 Europe Nasal Polyps Treatment Market Size by Application

7 China
7.1 China Nasal Polyps Treatment Market Size (2014-2019)
7.2 Nasal Polyps Treatment Key Players in China
7.3 China Nasal Polyps Treatment Market Size by Type
7.4 China Nasal Polyps Treatment Market Size by Application

8 Japan
8.1 Japan Nasal Polyps Treatment Market Size (2014-2019)
8.2 Nasal Polyps Treatment Key Players in Japan
8.3 Japan Nasal Polyps Treatment Market Size by Type
8.4 Japan Nasal Polyps Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Nasal Polyps Treatment Market Size (2014-2019)
9.2 Nasal Polyps Treatment Key Players in Southeast Asia
9.3 Southeast Asia Nasal Polyps Treatment Market Size by Type
9.4 Southeast Asia Nasal Polyps Treatment Market Size by Application

10 India
10.1 India Nasal Polyps Treatment Market Size (2014-2019)
10.2 Nasal Polyps Treatment Key Players in India
10.3 India Nasal Polyps Treatment Market Size by Type
10.4 India Nasal Polyps Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Nasal Polyps Treatment Market Size (2014-2019)
11.2 Nasal Polyps Treatment Key Players in Central & South America
11.3 Central & South America Nasal Polyps Treatment Market Size by Type
11.4 Central & South America Nasal Polyps Treatment Market Size by Application

12 International Players Profiles
12.1 OptiNose US
12.1.1 OptiNose US Company Details
12.1.2 Company Description and Business Overview
12.1.3 Nasal Polyps Treatment Introduction
12.1.4 OptiNose US Revenue in Nasal Polyps Treatment Business (2014-2019))
12.1.5 OptiNose US Recent Development
12.2 Regeneron Pharmaceuticals
12.2.1 Regeneron Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Nasal Polyps Treatment Introduction
12.2.4 Regeneron Pharmaceuticals Revenue in Nasal Polyps Treatment Business (2014-2019)
12.2.5 Regeneron Pharmaceuticals Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Nasal Polyps Treatment Introduction
12.3.4 Merck Revenue in Nasal Polyps Treatment Business (2014-2019)
12.3.5 Merck Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Nasal Polyps Treatment Introduction
12.4.4 Pfizer Revenue in Nasal Polyps Treatment Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 F. Hoffmann La-Roche
12.5.1 F. Hoffmann La-Roche Company Details
12.5.2 Company Description and Business Overview
12.5.3 Nasal Polyps Treatment Introduction
12.5.4 F. Hoffmann La-Roche Revenue in Nasal Polyps Treatment Business (2014-2019)
12.5.5 F. Hoffmann La-Roche Recent Development
12.6 Intersect ENT
12.6.1 Intersect ENT Company Details
12.6.2 Company Description and Business Overview
12.6.3 Nasal Polyps Treatment Introduction
12.6.4 Intersect ENT Revenue in Nasal Polyps Treatment Business (2014-2019)
12.6.5 Intersect ENT Recent Development
12.7 GlaxoSmithKline
12.7.1 GlaxoSmithKline Company Details
12.7.2 Company Description and Business Overview
12.7.3 Nasal Polyps Treatment Introduction
12.7.4 GlaxoSmithKline Revenue in Nasal Polyps Treatment Business (2014-2019)
12.7.5 GlaxoSmithKline Recent Development
12.8 Sanofi
12.8.1 Sanofi Company Details
12.8.2 Company Description and Business Overview
12.8.3 Nasal Polyps Treatment Introduction
12.8.4 Sanofi Revenue in Nasal Polyps Treatment Business (2014-2019)
12.8.5 Sanofi Recent Development
12.9 Novartis
12.9.1 Novartis Company Details
12.9.2 Company Description and Business Overview
12.9.3 Nasal Polyps Treatment Introduction
12.9.4 Novartis Revenue in Nasal Polyps Treatment Business (2014-2019)
12.9.5 Novartis Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Nasal Polyps Treatment Key Market Segments
Table Key Players Nasal Polyps Treatment Covered
Table Global Nasal Polyps Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Pharmacological Therapies Figures
Table Key Players of Pharmacological Therapies
Figuer Surgeries Figures
Table Key Players of Surgeries
Table Global Nasal Polyps Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Nasal Polyps Treatment Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Specialty Clinics Case Studies
Figure Nasal Polyps Treatment Report Years Considered
Figure Global Nasal Polyps Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Nasal Polyps Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Nasal Polyps Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Nasal Polyps Treatment Market Share by Regions 2014-2019
Figure Global Nasal Polyps Treatment Market Share by Regions 2014-2019
Figure Global Nasal Polyps Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Nasal Polyps Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Nasal Polyps Treatment Market Share by by Players (2014-2019)
Figure Global Nasal Polyps Treatment Market Share by by Players in 2018
Table Global Nasal Polyps Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Nasal Polyps Treatment Product/Solution/Service
Table Date of Enter into Nasal Polyps Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Nasal Polyps Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Nasal Polyps Treatment Market Size Share by Type (2014-2019)
Figure Global Nasal Polyps Treatment Market Size Market Share by Type (2014-2019)
Table Global Nasal Polyps Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Nasal Polyps Treatment Market Size Share by Application (2014-2019)
Figure Global Nasal Polyps Treatment Market Size Market Share by Application (2014-2019)
Figure Global Nasal Polyps Treatment Revenue Market Share by Application in 2018
Figure North America Nasal Polyps Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Nasal Polyps Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Nasal Polyps Treatment Market Share (2018-2019)
Table North America Nasal Polyps Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Nasal Polyps Treatment Market Share by Type 2014-2019
Table North America Nasal Polyps Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Nasal Polyps Treatment Market Share by Application 2014-2019
Figure Europe Nasal Polyps Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Nasal Polyps Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Nasal Polyps Treatment Market Share (2018-2019)
Table Europe Nasal Polyps Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Nasal Polyps Treatment Market Share by Type 2014-2019
Table Europe Nasal Polyps Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Nasal Polyps Treatment Market Share by Application 2014-2019
Figure China Nasal Polyps Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Nasal Polyps Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Nasal Polyps Treatment Market Share (2018-2019)
Table China Nasal Polyps Treatment Market Size by Type 2014-2019 (Million US$)
Table China Nasal Polyps Treatment Market Share by Type 2014-2019
Table China Nasal Polyps Treatment Market Size by Application 2014-2019 (Million US$)
Table China Nasal Polyps Treatment Market Share by Application 2014-2019
Figure Japan Nasal Polyps Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Nasal Polyps Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Nasal Polyps Treatment Market Share (2018-2019)
Table Japan Nasal Polyps Treatment Market Size by Type 2014-2019 (Million US$)
Table Japan Nasal Polyps Treatment Market Share by Type 2014-2019
Table Japan Nasal Polyps Treatment Market Size by Application 2014-2019 (Million US$)
Table Japan Nasal Polyps Treatment Market Share by Application 2014-2019
Figure Southeast Asia Nasal Polyps Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Nasal Polyps Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Nasal Polyps Treatment Market Share (2018-2019)
Table Southeast Asia Nasal Polyps Treatment Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Nasal Polyps Treatment Market Share by Type 2014-2019
Table Southeast Asia Nasal Polyps Treatment Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Nasal Polyps Treatment Market Share by Application 2014-2019
Figure India Nasal Polyps Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Nasal Polyps Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Nasal Polyps Treatment Market Share (2018-2019)
Table India Nasal Polyps Treatment Market Size by Type 2014-2019 (Million US$)
Table India Nasal Polyps Treatment Market Share by Type 2014-2019
Table India Nasal Polyps Treatment Market Size by Application 2014-2019 (Million US$)
Table India Nasal Polyps Treatment Market Share by Application 2014-2019
Figure Central & South America Nasal Polyps Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Nasal Polyps Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Nasal Polyps Treatment Market Share (2018-2019)
Table Central & South America Nasal Polyps Treatment Market Size by Type 2014-2019 (Million US$)
Table Central & South America Nasal Polyps Treatment Market Share by Type 2014-2019
Table Central & South America Nasal Polyps Treatment Market Size by Application 2014-2019 (Million US$)
Table Central & South America Nasal Polyps Treatment Market Share by Application 2014-2019
Table OptiNose US Company Details
Table OptiNose US Revenue in Nasal Polyps Treatment Business 2014-2019 (Million US$)
Figure OptiNose US Revenue Growth Rate in Nasal Polyps Treatment Business (2014-2019)
Table OptiNose US Recent Development
Table Regeneron Pharmaceuticals Company Details
Table Regeneron Pharmaceuticals Revenue in Nasal Polyps Treatment Business 2014-2019 (Million US$)
Figure Regeneron Pharmaceuticals Revenue Growth Rate in Nasal Polyps Treatment Business (2014-2019)
Table Regeneron Pharmaceuticals Recent Development
Table Merck Company Details
Table Merck Revenue in Nasal Polyps Treatment Business 2014-2019 (Million US$)
Figure Merck Revenue Growth Rate in Nasal Polyps Treatment Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Nasal Polyps Treatment Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Nasal Polyps Treatment Business (2014-2019)
Table Pfizer Recent Development
Table F. Hoffmann La-Roche Company Details
Table F. Hoffmann La-Roche Revenue in Nasal Polyps Treatment Business 2014-2019 (Million US$)
Figure F. Hoffmann La-Roche Revenue Growth Rate in Nasal Polyps Treatment Business (2014-2019)
Table F. Hoffmann La-Roche Recent Development
Table Intersect ENT Company Details
Table Intersect ENT Revenue in Nasal Polyps Treatment Business 2014-2019 (Million US$)
Figure Intersect ENT Revenue Growth Rate in Nasal Polyps Treatment Business (2014-2019)
Table Intersect ENT Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Nasal Polyps Treatment Business 2014-2019 (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Nasal Polyps Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Nasal Polyps Treatment Business 2014-2019 (Million US$)
Figure Sanofi Revenue Growth Rate in Nasal Polyps Treatment Business (2014-2019)
Table Sanofi Recent Development
Table Novartis Company Details
Table Novartis Revenue in Nasal Polyps Treatment Business 2014-2019 (Million US$)
Figure Novartis Revenue Growth Rate in Nasal Polyps Treatment Business (2014-2019)
Table Novartis Recent Development
Table Global Nasal Polyps Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Nasal Polyps Treatment Market Size Share by Regions (2019-2025)
Figure Global Nasal Polyps Treatment Market Size Share by Regions in 2025
Figure North America Nasal Polyps Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Nasal Polyps Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Nasal Polyps Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Nasal Polyps Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Nasal Polyps Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Nasal Polyps Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Nasal Polyps Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Nasal Polyps Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Nasal Polyps Treatment Market Size by Product (2019-2025)
Figure Global Nasal Polyps Treatment Market Size by Product in 2025
Table Global Nasal Polyps Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Nasal Polyps Treatment Market Size by Application (2019-2025)
Figure Global Nasal Polyps Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

OptiNose US、Regeneron Pharmaceuticals、Merck、Pfizer、F. Hoffmann La-Roche、Intersect ENT、GlaxoSmithKline、Sanofi、Novartis

★調査レポート[鼻ポリープ治療の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18739)販売に関する免責事項を必ずご確認ください。
★調査レポート[鼻ポリープ治療の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 鼻ポリープ薬の世界市場：規模・現状・予測2019-2025
    DATA909X18738 / QYResearch / 2019年11月25日 / ※当調査レポートでは、鼻ポリープ薬の世界市場について調査・分析し、鼻ポリープ薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（コルチコステロイド、抗生物質、ロイコトリエン阻害剤、その他）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の鼻ポリープ薬市場動向 ・主要企業別マーケットシェア ・鼻ポリープ薬の種類別市場規模2014-2019 （コルチコステロイド、抗生物質、ロイコトリエン阻害剤、その他） ・鼻ポリープ薬の用途別市場規模2014-2019 （病院、クリニック、その他） ・鼻ポリープ薬の北米市場：主要企業・種類別/用途別市場規模 ・鼻ポリープ薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Nasal polyps (NP) are noncancerous growths within the nose or sinuses. Symptoms include trouble breathing through the nose, loss of smell, decreased taste, post nasal drip, and a runny nose. The growths are sac-like, movable, and nontender, though face pain may occasionally occur. They typically occur in both nostrils in those who are affected. Complications may include sinusitis and broadening of the nose.In 2018, the global Nasal Polyps Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on...
  • 副鼻腔炎治療薬の世界市場：規模・現状・予測2019-2025
    DATA909X18972 / QYResearch / 2019年11月25日 / ※当調査レポートでは、副鼻腔炎治療薬の世界市場について調査・分析し、副鼻腔炎治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗生物質、NSAIDS、充血除去剤および粘液溶解剤、鼻洗浄キット）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の副鼻腔炎治療薬市場動向 ・主要企業別マーケットシェア ・副鼻腔炎治療薬の種類別市場規模2014-2019 （抗生物質、NSAIDS、充血除去剤および粘液溶解剤、鼻洗浄キット） ・副鼻腔炎治療薬の用途別市場規模2014-2019 （病院、診療所、その他） ・副鼻腔炎治療薬の北米市場：主要企業・種類別/用途別市場規模 ・副鼻腔炎治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Sinusitis is an inflammation or swelling of the tissue lining the sinuses.In 2018, the global Sinusitis Treatment Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Sinusitis Treatment Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sinusitis Treatment Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study Pfizer, Inc. Janssen Pharmaceuticals...
  • 緑膿菌感染症治療の世界市場：規模・現状・予測2019-2025
    DATA909X18876 / QYResearch / 2019年11月25日 / ※当調査レポートでは、緑膿菌感染症治療の世界市場について調査・分析し、緑膿菌感染症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（鼻、経口、静脈内）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の緑膿菌感染症治療市場動向 ・主要企業別マーケットシェア ・緑膿菌感染症治療の種類別市場規模2014-2019 （鼻、経口、静脈内） ・緑膿菌感染症治療の用途別市場規模2014-2019 （病院薬局、小売薬局、オンライン薬局） ・緑膿菌感染症治療の北米市場：主要企業・種類別/用途別市場規模 ・緑膿菌感染症治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...In 2018, the global Pseudomonas Aeruginosa Infection Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Pseudomonas Aeruginosa Infection Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pseudomonas Aeruginosa Infection Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study Allergan Teva Pharmaceutical Industries Pfizer Lupin Pharmaceuticals AstraZeneca Merck Bristol-Myers Squibb Janssen...
  • 胆道閉鎖症治療の世界市場：規模・現状・予測2019-2025
    DATA909X18226 / QYResearch / 2019年11月25日 / ※当調査レポートでは、胆道閉鎖症治療の世界市場について調査・分析し、胆道閉鎖症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物治療、外科治療）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の胆道閉鎖症治療市場動向 ・主要企業別マーケットシェア ・胆道閉鎖症治療の種類別市場規模2014-2019 （薬物治療、外科治療） ・胆道閉鎖症治療の用途別市場規模2014-2019 （病院、診療所、その他） ・胆道閉鎖症治療の北米市場：主要企業・種類別/用途別市場規模 ・胆道閉鎖症治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Biliary atresia or extra hepatic ductopenia is an acquired disease of the liver. This disease is characterized by the obliteration of the extra hepatic biliary system which results in obstruction of the bile flow from the liver to gall bladder.In 2018, the global Biliary Atresia Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Biliary Atresia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biliary...
  • 悪性腹水治療の世界市場：規模・現状・予測2019-2025
    DATA909X18661 / QYResearch / 2019年11月25日 / ※当調査レポートでは、悪性腹水治療の世界市場について調査・分析し、悪性腹水治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（穿刺、化学療法、外科的治療）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の悪性腹水治療市場動向 ・主要企業別マーケットシェア ・悪性腹水治療の種類別市場規模2014-2019 （穿刺、化学療法、外科的治療） ・悪性腹水治療の用途別市場規模2014-2019 （病院、クリニック、その他） ・悪性腹水治療の北米市場：主要企業・種類別/用途別市場規模 ・悪性腹水治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Ascites are characterized by excess fluid formation in the abdominal cavity, especially in the peritoneal cavity. It causes the body to lose fluids. When ascites develop due to cancer, it is called malignant peritoneal effusion or malignant ascites.In 2018, the global Malignant Ascites Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Malignant Ascites Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Malignant Ascites Treatment...

    • ◆H&Iグローバルリサーチのお客様（例）◆